Mechanistically, high TFRC expression negatively correlates with the infiltration levels of key anti-tumor immune cells such as CD8+ T cells and positively correlates with immunosuppressive cells like Th2 cells, suggesting it promotes disease progression and poor prognosis by modulating the tumor immune microenvironment (29, 30). This evidence concerns the gene CD8A and neoplasm.